Our service for you
We at RBP are here to help you!
Explore our comprehensive service section and our RBP distribution partners worldwide. If you would like more information or to contact us directly, we are here to help.
Pharmaceutical Packaging 2035: Towards a Circular Future
Introduction
The transformation of pharmaceutical packaging is already underway.
Driven by regulatory frameworks such as the Packaging and Packaging Waste Regulation (PPWR), the pharmaceutical industry is increasingly exploring new approaches to packaging design, material selection and waste management. What began as a regulatory discussion about packaging waste is now evolving into a broader transformation of pharmaceutical packaging systems. Over the coming decade, several technological and regulatory trends are likely to reshape the industry.
Design for Recycling
One of the key principles emerging from the PPWR is Design for Recycling. Packaging systems must increasingly be designed with their end-of-life phase in mind.
For pharmaceutical blister packaging, this means that materials, structures and packaging concepts will gradually evolve toward solutions that are more compatible with recycling infrastructures. Developments such as mono-material blister systems represent early steps in this direction.
Digital Transparency
Another important development is the increasing use of digital product information systems. Concepts such as the Digital Product Passport could improve transparency across packaging supply chains. Digital information attached to packaging could enable better tracking of material composition, recycling compatibility and product lifecycle data. This may help improve sorting and recycling processes in the future.
Material Recovery Technologies
In addition to new materials, material recovery technologies will play a crucial role in enabling circular packaging systems. Processes that allow efficient separation of pharmaceutical products and packaging materials can help support recycling and waste reduction. Technologies such as deblistering systems therefore represent an important link between pharmaceutical production and circular material flows. Industrial solutions such as the depaq systems developed by RBP BAUER GmbH demonstrate how advanced processing technologies can support this transition.
A New Packaging Ecosystem
Taken together, these developments may lead to a fundamentally different pharmaceutical packaging ecosystem. In this future system:
- packaging materials are designed for recycling
- digital systems improve material transparency
- processing technologies enable material recovery.
Packaging would no longer be viewed solely as a protective component of pharmaceutical products. Instead, it would become part of a broader circular material system.
Outlook
The transformation of pharmaceutical packaging will not happen overnight. However, the combination of regulatory pressure, technological innovation and sustainability goals is already accelerating change across the industry. The coming decade will likely determine how successfully pharmaceutical packaging systems can transition toward circular economy models. And the technologies that enable this transition may define the next generation of pharmaceutical packaging innovation.